Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630561 · ClinicalTrials.gov registry record · NA
Great Posture, Great Health
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT04630561: Completed NA study, sponsored by Mayo Clinic.
NCT04630561 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04630561, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of a posture intervention on specific areas of daily function and health: physical, psychological, cognitive, social, and environmental characteristics.
Primary Outcome
Isometric measurement (Newtons) of quadriceps and hamstrings musculature
Interventions
- BEHAVIORAL Postural Intervention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2024-03-19 |
| Phase | NA |
What the finished NCT04630561 record still lists
NCT04630561 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Postural Intervention Program is the first listed.
NCT04630561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04630561 about?
NCT04630561 is a clinical study titled "Great Posture, Great Health". The purpose of this study is to examine the effect of a posture intervention on specific areas of daily function and health: physical, psychological, cognitive, social, and environmental characteristics.
What is the current status of trial NCT04630561?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2020-11-19. Estimated completion is 2024-03-19.
What interventions are being tested in trial NCT04630561?
The interventions under investigation include: Postural Intervention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04630561?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04630561's enrollment target sits among peer trials
114 811th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI